Fig. 5
From: IL-17A promotes the progression of Alzheimer’s disease in APP/PS1 mice
Effect of IL-17A on the activity and phagocytosis of BV2 cells. A Effect of IL-17A concentration on BV2 cell activity as shown by the CCK8 method. B Phagocytosis efficiency of BV2 cells incubated with IL-17A as determined with a fluorescent phagocytosis assay with latex beads. C Quantitative analysis of the number of latex beads that were phagocytosed by BV2 cells that were treated with Aβ and/or IL-17A. The values are expressed as the mean ± standard deviation (****P < 0.0001, ***P < 0.001, **P < 0.01, and *P < 0.05). The data are representative of at least three independent experiments